Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0UK4O
|
||||
| Former ID |
DNC014134
|
||||
| Drug Name |
KATSUMADAIN A
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530582] | ||
| Formula |
C32H28O4
|
||||
| Canonical SMILES |
C1C(OC2=C(C1C3=CC=CC=C3)C(=O)OC(=C2)C=CC4=CC=CC=C4)CC(=<br />O)CCC5=CC=CC=C5
|
||||
| InChI |
1S/C32H28O4/c33-26(18-16-23-10-4-1-5-11-23)20-28-21-29(25-14-8-3-9-15-25)31-30(35-28)22-27(36-32(31)34)19-17-24-12-6-2-7-13-24/h1-15,17,19,22,28-29H,16,18,20-21H2/b19-17+/t28-,29+/m1/s1
|
||||
| InChIKey |
IAIGBNIWSBFKNA-FIACUDKOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530582] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||